Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

CD4-CD8-αβ and γδ T cells display inflammatory and regulatory potentials during human tuberculosis.

Pinheiro MB, Antonelli LR, Sathler-Avelar R, Vitelli-Avelar DM, Spindola-de-Miranda S, Guimarães TM, Teixeira-Carvalho A, Martins-Filho OA, Toledo VP.

PLoS One. 2012;7(12):e50923. doi: 10.1371/journal.pone.0050923. Epub 2012 Dec 11.

2.

Expression of Shigella flexneri gluQ-rs gene is linked to dksA and controlled by a transcriptional terminator.

Caballero VC, Toledo VP, Maturana C, Fisher CR, Payne SM, Salazar JC.

BMC Microbiol. 2012 Oct 5;12:226. doi: 10.1186/1471-2180-12-226.

3.

[Meaning of psychosis by the subject and its effects on clinical nursing].

Marques NA, Toledo VP, Garcia AP.

Rev Bras Enferm. 2012 Jan-Feb;65(1):116-20. Portuguese.

4.

[Air transport of patients: analysis of scientific knowledge].

Passos IP, Toledo VP, Duran EC.

Rev Bras Enferm. 2011 Nov-Dec;64(6):1127-31. Review. Portuguese.

5.

[Analysis of knowledge production on the nursing process: exploratory descriptive study].

Duran EC, Toledo VP.

Rev Gaucha Enferm. 2011 Jun;32(2):234-40. Portuguese.

PMID:
21987982
6.

Evaluation of miltefosine for the treatment of dogs naturally infected with L. infantum (=L. chagasi) in Brazil.

Andrade HM, Toledo VP, Pinheiro MB, Guimarães TM, Oliveira NC, Castro JA, Silva RN, Amorim AC, Brandão RM, Yoko M, Silva AS, Dumont K, Ribeiro ML Jr, Bartchewsky W, Monte SJ.

Vet Parasitol. 2011 Sep 27;181(2-4):83-90. doi: 10.1016/j.vetpar.2011.05.009. Epub 2011 May 14.

7.

[Nursing process to patients with anorexia nervosa].

Toledo VP, Ramos NA, Wopereis F.

Rev Bras Enferm. 2011 Jan-Feb;64(1):193-7. Portuguese.

8.

Increase of NK cells and proinflammatory monocytes are associated with the clinical improvement of diffuse cutaneous leishmaniasis after immunochemotherapy with BCG/Leishmania antigens.

Pereira LI, Dorta ML, Pereira AJ, Bastos RP, Oliveira MA, Pinto SA, Galdino H Jr, Mayrink W, Barcelos W, Toledo VP, Lima GM, Ribeiro-Dias F.

Am J Trop Med Hyg. 2009 Sep;81(3):378-83.

9.

Natural killer cell subpopulations in putative resistant individuals and patients with active Mycobacterium tuberculosis infection.

Barcelos W, Sathler-Avelar R, Martins-Filho OA, Carvalho BN, Guimarães TM, Miranda SS, Andrade HM, Oliveira MH, Toledo VP.

Scand J Immunol. 2008 Jul;68(1):92-102. doi: 10.1111/j.1365-3083.2008.02116.x. Epub 2008 May 14.

PMID:
18484953
10.

[The psychiatric nurse in a state institution: descriptive-exploratory study].

Saidel MG, Toledo VP, do Amaral GR, Duran EC.

Rev Gaucha Enferm. 2007 Jun;28(2):200-6. Portuguese.

PMID:
17907641
11.

Acute and chronic toxicological studies of Dimorphandra mollis in experimental animals.

Féres CA, Madalosso RC, Rocha OA, Leite JP, Guimarães TM, Toledo VP, Tagliati CA.

J Ethnopharmacol. 2006 Dec 6;108(3):450-6. Epub 2006 Jun 23.

PMID:
16872769
12.

Pulmonary tuberculosis: evaluation of interferon-gamma levels as an immunological healing marker based on the response to the Bacillus Calmette-Guerin.

Moura EP, Toledo VP, Oliveira MH, Spíndola-de-Miranda S, Andrade HM, Guimarães TM.

Mem Inst Oswaldo Cruz. 2004 May;99(3):283-7. Epub 2004 Jul 19.

13.

Technetium-99m labeling anti-amastigote polyclonal antibodies of Leishmania amazonensis.

Araujo JG, Toledo VP, Guimarães TM, Bernardo-Filho M, Simal CJ, Mota LG, Diniz SO, Cardoso VN.

Nucl Med Biol. 2002 May;29(4):405-11.

PMID:
12031875
14.

A randomized double-blind placebo-controlled trial to evaluate the immunogenicity of a candidate vaccine against American tegumentary leishmaniasis.

De Luca PM, Mayrink W, Pinto JA, Coutinho SG, Santiago MA, Toledo VP, Costa CA, Genaro O, Reis AB, Mendonça SC.

Acta Trop. 2001 Dec 21;80(3):251-60.

PMID:
11700183
15.

Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment.

Toledo VP, Mayrink W, Gollob KJ, Oliveira MA, Costa CA, Genaro O, Pinto JA, Afonso LC.

Mem Inst Oswaldo Cruz. 2001 Jan;96(1):89-98.

16.

Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis.

De Luca PM, Mayrink W, Alves CR, Coutinho SG, Oliveira MP, Bertho AL, Toledo VP, Costa CA, Genaro O, Mendonça SC.

Vaccine. 1999 Mar 5;17(9-10):1179-85.

PMID:
10195630
17.

Phase I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs.

Mayrink W, Genaro O, Silva JC, da Costa RT, Tafuri WL, Toledo VP, da Silva AR, Reis AB, Williams P, da Costa PW.

Mem Inst Oswaldo Cruz. 1996 Nov-Dec;91(6):695-7. No abstract available.

18.

Vaccine for prophylaxis and immunotherapy, Brazil.

Genaro O, de Toledo VP, da Costa CA, Hermeto MV, Afonso LC, Mayrink W.

Clin Dermatol. 1996 Sep-Oct;14(5):503-12. Review. No abstract available.

PMID:
8889328
19.

Montenegro skin test--evaluation of the composition and stability of the antigen preparation.

da Costa CA, de Toledo VP, enaro O, Williams P, Mayrink W.

Mem Inst Oswaldo Cruz. 1996 Mar-Apr;91(2):193-4. No abstract available.

20.

Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis.

Mendonca SC, De Luca PM, Mayrink W, Restom TG, Conceicao-Silva F, Da-Cruz AM, Bertho AL, Da Costa CA, Genaro O, Toledo VP, et al.

Am J Trop Med Hyg. 1995 Aug;53(2):195-201.

PMID:
7677224
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk